The Efficacy of Transdermal Rivastigmine in Mild to Moderate Alzheimer’s Disease with Concomitant Small Vessel Cerebrovascular Disease: Findings from an Open-Label Study

BACKGROUND: Rivastigmine is used to treat cognitive impairment in Alzheimer’s disease (AD); however, the efficacy of Rivastigmine in patients with AD and concomitant small vessel cerebrovascular disease (svCVD) remains unclear. We investigated the effectiveness of Rivastigmine Patch in patients with...

Descripción completa

Detalles Bibliográficos
Autores principales: Yatawara, Chathuri, Zailan, Fatin Zahra, Chua, Esther Vanessa, Lim, Linda Lay Hoon, Silva, Eveline, Wang, Joanna Sihan, Ng, Adeline, Ng, Kok Pin, Kandiah, Nagaendran
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7903964/
https://www.ncbi.nlm.nih.gov/pubmed/33642856
http://dx.doi.org/10.2147/CIA.S290055

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7903964/
https://www.ncbi.nlm.nih.gov/pubmed/33642856
http://dx.doi.org/10.2147/CIA.S290055

Ejemplares similares